Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #15,551 to #15,600.
- Administrative Controlled Substances Code Number (1 revision)
- Administrator intervention against vandalism (1 revision)
- Admissible decision rule (1 revision)
- Ado-Trastuzumab Emtansine (1 revision)
- Adolescent X-linked adrenoleukodystrophy (1 revision)
- Adonis aestivalis (1 revision)
- Adonis annua (1 revision)
- Adosterol (1 revision)
- Adp-ribosyltransferase 5 (1 revision)
- Adrenal artery (1 revision)
- Adrenal cortex (1 revision)
- Adrenal fatigue (patient information) (1 revision)
- Adrenal fatigue CT (1 revision)
- Adrenal fatigue MRI (1 revision)
- Adrenal fatigue case study one (1 revision)
- Adrenal fatigue classification (1 revision)
- Adrenal fatigue cost-effectiveness of therapy (1 revision)
- Adrenal fatigue differential diagnosis (1 revision)
- Adrenal fatigue epidemiology and demographics (1 revision)
- Adrenal fatigue future or investigational therapies (1 revision)
- Adrenal fatigue historical perspective (1 revision)
- Adrenal fatigue laboratory findings (1 revision)
- Adrenal fatigue medical therapy (1 revision)
- Adrenal fatigue natural history, complications and prognosis (1 revision)
- Adrenal fatigue other diagnostic studies (1 revision)
- Adrenal fatigue other imaging findings (1 revision)
- Adrenal fatigue overview (1 revision)
- Adrenal fatigue pathophysiology (1 revision)
- Adrenal fatigue physical examination (1 revision)
- Adrenal fatigue primary prevention (1 revision)
- Adrenal fatigue risk factors (1 revision)
- Adrenal fatigue screening (1 revision)
- Adrenal fatigue secondary prevention (1 revision)
- Adrenal fatigue surgery (1 revision)
- Adrenal fatigue ultrasound (1 revision)
- Adrenal ferredoxin (1 revision)
- Adrenal gland (1 revision)
- Adrenal hemorrhage echocardiography or ultrasound (1 revision)
- Adrenal tumor electrocardiogram (1 revision)
- Adrenarche (1 revision)
- Adrenocortical primary prevention (1 revision)
- Adrenoleukodystrophy case study one (1 revision)
- Adrenoleukodystrophy electroencephalogram (1 revision)
- Adrenosterone (1 revision)
- Adsorption (1 revision)
- Adult (1 revision)
- Adult Blood Lead Epidemiology and Surveillance (1 revision)
- Adult stem cell (1 revision)
- Adulterant (1 revision)
- Advanced Cell Technology (1 revision)